                                              2.5 January 1960
             Dr. Rudolf Bircher-
             Sando-- Phar:.mccuticals
             Sar.doz, Inc.
               novt->r,, Nea Jersey
             Dcar ILr. Bircher:
             t@,le ha-ve il.'In-ally conpleted our study o,,i tolerance to psilocybin
        2     and LSL"-25 and cross-tolerance@.bcti-?ecn ti'iesc drugs in five
             subjects, supplc,-,,-,nting the earlier'study o.,'L' Dr. Isbell on
             .".'ive      sublec",,s,  '"he tables enclosed represent t@,,e
             cor,-.b.-'Lner-I data on all ten subjects*
             ,As @rou will note in Tabl-2'-' 3,, C-icra is no cloubt th,,,-t o*jr
             subjec4.,.s dcvelotled tolerance to LSD-25 (1-5                and
             after t.@iey          tolerant to this drugs t.-toy exhatbited c4-ost-
             tole,--a-,ice -to rsLIoc@ybin (1'P'O          wit'.i r2esdect  to  all
             r.eas@ares except possibly t:ie tc.-i-jerature-clevating effect of
             tlic-l la-'O,.ter druo.  .%@-@n tie otie,- hand, tle evidenc@;; for develor,,--cn,&"
             of  tolerance  to  @silocybin  Is  not  so  coi,-plate   (altlioughly
             strongly s,.:r 2astive), and o  several r,.-,c,,,sures (tei-,.-)era""ure,
                          jo                  n                               1.
             blo6d pressure and knee jerk), tic sublects re=-ained reactive
                                                           .1
             to  LSD-25,  aftizr  c.ironi%-.  atimin2istration  of  psilocybin  for
             seven days.
             One possible reason for t.ie failure to demonstrate tolerance
             to psiloc,,rbin and cross-'6o.'Lerancc to LSD-2.-@ o.-i all -casures.
             is suo-estcd by t'.Iic data in T,,-ble I which lnd!cate thatp at
             least wit.-& resncct tb *.:-icir   2        on  pupillary  -%Ize   and
             responses to qtt-cstio.-iraire, tlie            doscs of LSD-25 and
              silocy-bin it,,e used tiere not cauloot4. @-,nt -- i.e.9 LSD-21@
                   r,4cg/,kc) proxj.,,iced grcatcr c.,.-fects than psilocybin
        2            --/'"-g), a:-.cVorl     period of c@irciiic adr-l.Li,.istration
             of
                 ,Isilocybin i-.as too  s.iort.

                   Since  the  c-"-Iertion  of  tolaran,-e  and  cros-,t--tolcrance  In  regard
                   to  psilocysin -And Z'.SZ)-2'  Is  of  considerable  ticoretical
                   sio.-Oif                  ,ac      arc                  :>i-  doing  aziotlier  study,  wit.@i
              2     la-ger  @ioses  of p@siloci,4.)In  k'possibly u,:7  to  250                                          ;i:axirz."L
                   laou.-)  and  lo,-iner                          of       c!irciiic       iiitoxicztion        (1;        days).
                                                                                                  2                 4
                   To  do  this  In  t:,;ie  few riont.is  I  stilal                             rer,-.aining before
                   my prospcct!vc  sabbal;.cal  y,-ar'ab@-oad..  t,,,e  t-jill  hav.-i                             to  us--
                   ten new subjccts and  I.-.eci-in  t-l-ie  s",,,tLciy wit,iln  $'-,vjo                              at   t."x,-.
                                        Also                           .6     %.                                          ,It %;C
                                           .7  uN--  !-.,avc,.                    tha"L'    i.,i                 to iii
                   .h-"ve  lea@'t  of  tl,"ic  sunply of  p.-biloc:ibin you  so  .'@@,-*nclily
                   a     f.,,w     rontiis af-lo.,  ,.zra  t-.,ou.'&d                          L:',,,;  u:,an:;          c;zrplet.lon
                   of  tl.it>,  exper.1.1rent.
         2                                                                           c;,rj(;rL74-@n"      until      we      liave
                   Ur,f c r Jt" i,.ra *@, El, 1I     a,-                                             6
                   the          cor-,plete                   psilocy',--in     on     @la.-id,     sinca     ae     mu-,2t      do
                   so..m-  prelir.--irarv                      of        rctia:t-,,ie
                                               w          , s                 I&         L- 44
                   oursc-l,,.,,e.s      to          L,  Ic,,nc; and
                   ,k.erefore.,  '-de  dzclsion                               or  not  A2,  o  iLi   d,--   rLa.',.m   tlie   natt
                   studv     deze-,ids     on     t4lie     possibility      of      your      being      able      '6o      send
                   US @:0 E@OZ"S of PZT                                     4 a 6              %.
                                                        C, C     4-1  w i 4@@2.      r.Q .1 I C  x   -a ci  v.-.. C !.I%- 3
                   I  realize  tizt  tlile,,  Os  an  eytraordlz,,ar,,,7                                   a,-.d     that      @mu
                                                        4
                   m@-Y   4-,Ot   '.-iava   til.at    -,u'c.-i nsil--cytir.  o.-4 h-and.
                   be    very    c.-ateful    if    v    u    will     let     r@c     1,--w     aa     soon     as     possiblr,-
                   uftat  tlic  prosoacts are,
                   Wlt'.,i many                   Al'or  ycur     as3istance,,        past        rrd        present.,        and
                                      2     r-..,mrdc*
                                                                          Sincercly,
                                                                         ,i%ctino Dircct.-,r
                   AW: biis
                   Enclosures

                                        Table I
                    Differences in Response to Coatrol Doses of
                                LSD  and Psilocybin
                                                     D I FF.' R El,C L@:1 l@.1 RESPCNSR@-
                Te,.nperature                          0.31      0.43
                Pulse Rate                           +27-55 t  13-52
      2          Blood Pressure                       +34.75  t   16-23
                Punlhllary Size                      + 4..54 i
                Knee Jerk                            + 8.Lt,7 t  22-40
                Responses on Questioanalre           +39-25 1  12-30
                Clinical C;rade                      + 0.35  i  0.25
           Figures reprzsent mean differences t standard 2errors of the
         difi0erences betmeen means. of responses to tvro control doses of
         LSD-2;'@ (1-5 mcg/kg) and mean3 of responses to tv.,o control doses
         of Psilocybin (.150 mcg/kg).
           Notes*         P < .02
                          p    0 1
                       Indicates LSD-25 stronger in effect than Ps1ilocybin
                       indicates Psilocybin strong--r In effect than Lc-D-e'_5

                                    Table  2
                                                                -25
                                               1.5 mcg/kg of LSD
         Differences in Responses to Placebos
                          of Psilocybin on first and secono  controls*
           and i5o mcg/itg,
                                         D tl Uri
        r-i ir           Plac2eb6            LSD-25            PsilocNibin
    Temperature        + 0.98    -,0.63 +'-0.42--i   o.64    1.24 i  0.5
    Pulse Rate         -11-53  i   13.30 selp-.62  18-40   .19.60    9.30
    Blood Pressure     -  i.lo  i  15-70 - 1.35  i  12-70  -25-40   11-60
    Funillary Size     - 0.29  :t  .21.65 + O..5P- t  1-18  + o.io    o.33
    Knee  Jerk         W12-56  t   11.90 @14-83  t  21-75  4-17.BS i 18-70
    Responses on
    Questionnaire      +  0.90  i   1.31 +  0.60  t  6.10  + 4.90    9.65
    Clinical Grad4     +  0.10  t   0.10   0-30  ±   0-20  + O.Po-t:  o.41
          Figures2 represent the mean differences t standard errors of the
     diffe@ences between measureme.-its on the first and second controls In
     10 subjects'                          exce-ot th t for temperature
                   None of the difference-           a
     Change after psilocybiq were significant.
          Indicates that the average measurement was Increased on the
          second control,
          Indicates that it was decreased.
        1  p  .05

                                                                      Table 3
                                     Differences between Control Respon3e to     LSD-25 and Psilocybin and
                                             Response after Chronic Administration of either Drug.
                                                                                          After Psiloc,
                                                 2After  LSD  Chronically__                             ybin Ciironicall)r
                                               LSD              Psilocybin         t       Psilocybin           LSD
                     f-leasure                                               cc)    'Direct" Tolernncel vcro--.--." Tolerance
                        ,%erature      1.-93    0.79        1) - 1.85 t  0.61"*  1) - 1.87 t  0.1@7*"""* - o.5o -i  o.59
                                                            2) - o.62 ±  o.67      2) - o.63 I  0-it7
                     Pulse Rate                                        t i6.6o        -22,20 t 11.90a
                                     -47*70                    -17-05                        2             -33-05
                     Blood Pressure -79-60   1                 -30-75  t  7.33        -33-55 1 10-15      .23-70@± 15-30
                     Pupillary Size -11-75   i   1. 6,,74"ti@      5.77i  1.5r34p'@l@   3-17 t   1.20*    - 4.72 ±
                     Knee Jerlt                23-55"-"@'      .67-8t@   16.97*."M    -52.69 t 10-03*""'  -41-79 . 19.5,a
                                     -71.16
                     Rcsponses on                                                                    b
                     Questionnaire  -63.00                     -21485  i  5.52        -16-95 i  7.69     .-57-10   19.20
                     Clinical Grad               0.3               1.235t  0,17          0.95 1
                                    e - i.65 i                                                   0.23-S     1.40    Oo32&@
                     4" at   1.    Indicates.differences obtained,     using first contr6l values,
                             2, Indicates differences   obtaineo.     using second control values
                             Figures represent   the mean   differe2nces   ±standard errors between the average of the two
                             controls (with the exception of I and 2 which were significantly-different) and the values
                             found .@tien patient was tested with LSD.25 or psilocybin after receiving either drug clironically
                                    P  .05                            P  >*05# < *10
                                    P  .02          1            b,    t -. 2.20
                                    P  .01                            (at t c 2.260 P     o5)

